期刊文献+

慢病毒载体介导的层黏连蛋白受体稳定抑制细胞株的建立

Construction of Laminin Receptor Inhibited Stable Cell Line Mediated by Lentivirus Vector
下载PDF
导出
摘要 目的:构建靶向层黏连蛋白受体(LR)基因的小发卡RNA(sh RNA)慢病毒表达载体,鉴定其对LR的抑制效果,并筛选LR稳定抑制的He La细胞株。方法:设计针对LR的sh RNA序列,将此序列和H1启动子克隆入含有EGFP报告基因的p Lenti6/v5慢病毒表达载体,通过病毒包装、细胞感染、抗生素筛选获得稳定细胞株,用real-time PCR和Western印迹检测筛选得到的稳定细胞株中LR的表达水平。结果和结论:构建了含有LR靶向sh RNA的慢病毒表达载体,包装成病毒后感染He La细胞,经抗生素筛选后获得了稳定抑制LR的细胞株;筛选后的细胞均可观察到报告基因EGFP的表达;经m RNA和蛋白水平检测,LR-sh6和LR-sh7均可显著抑制He La细胞株中LR的表达。 Objective: To construct the lentiviral vector expressing laminin receptor(LR) targeted small hairpin RNA(shRNA) and the stable LR inhibited HeLa cells. Methods: shRNA sequences were designed, and together with H1 promoter were cloned into pLenti6/v5 vector with EGFP report gene. After virus packaging, infecting and cell screening, real-time PCR and Western blot analysis were conducted to determine LR expression in HeLa cells. Results & Conclusion: The lentiviral vectors carrying LR shRNA were successfully constructed. LR knocked-down stable HeLa cell lines were established and positive clones were observed to express EGFP. Real-time PCR and Western blot analysis indicated that both LR-sh6 and LR-sh7 could suppress LR expression effi?ciently.
出处 《生物技术通讯》 CAS 2014年第6期796-799,共4页 Letters in Biotechnology
关键词 层黏连蛋白受体 慢病毒载体 RNA干扰 HELA细胞 laminin receptor lentiviral vector RNA interference HeLa cell
  • 相关文献

参考文献9

  • 1Terranova V P, Rao C N, Kalebic T, et al. Laminin receptor on human breast carcinoma cells[J]. Proc Natl Acad Sci USA, 1983,80(2):444-448.
  • 2Givant-Horwitz V, Davidson B, Reich R. Laminin-induced sig- naling in tumor cells: the role of the M(r) 67 000 laminin re- ceptor[J]. Cancer Res, 2004,64(10):3572-3579.
  • 3方芳,朱平.慢病毒载体的改进为基因治疗带来了新的希望[J].中国实验血液学杂志,2013,21(5):1336-1339. 被引量:10
  • 4Volkel D, Blankenfeldt W, Schomburg D. Large-scale produc- tion, purification and refolding of the full-length cellular pri- on protein from Syrian golden hamster in Escherichia coli us- ing the glutathione S-transferase-h:sion system[J]. Eur J Bio- them, 1998,251 (1-2):462-471.
  • 5Morel E, Andrieu T, Casagrande F, et al. Bovine prion is en- docytosed by human enterocytes via the 37 kDa/67 kDa lam- inin receptor[J]. Am J Pathol, 2005,167(4):1033-1042.
  • 6Yow H K, Wong J M, Chen H S, et al. Increased mRNA ex- pression of a laminin-binding protein in human colon carcino- ma: complete sequence of a full-length cDNA encoding the protein[J]. Proc Natl Acad Sci USA, 1988,85(17):6394-6398.
  • 7Mercurio A M, Bachelder R E, Chung J, et al. Integrin lam- inin reeeptors and breast carcinoma progression[J]. J Mamma- Gland Biol Neoplasia, 2001,6(3):299-309.
  • 8Kemperman H, Driessens M H, La Riviere G, et al. Adhe- sion mechanisms in liver metastasis formation[J]. Cancer Surv, 1995,24:67-79.
  • 9Berno V, Porrini D, Castiglioni F et al. The 67 kDa laminin receptor increases tmnor aggressiveness by remodeling laminin- l[J]. Endocr Relat Cancer, 2005,12(2):393-406.

二级参考文献41

  • 1王逸群,朱平.遗传性铁粒幼细胞贫血研究进展及基因治疗的可能性[J].中国实验血液学杂志,2005,13(3):524-528. 被引量:4
  • 2胡绍燕,陈子兴,赵晔,岑建农,谷敏,傅铮铮,何军,顾伟英.WT1基因启动子和增强子在不同细胞株中的转录活性研究[J].中国实验血液学杂志,2007,15(5):1050-1055. 被引量:3
  • 3Hacein-Bey-Abina S,Le Deist F,Carlier F,et al.Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.N Eng J Med,2002;346(16):1185-1193.
  • 4Gaspar HB,Parsley KL,Howe S,et al.Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.The Lancet,2004 ;364 (9452):2181-2187.
  • 5AA.Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.J Clin Investig,2007 ; 117 (8):2233-2240.
  • 6Hacein-Bey-Abina S,Garrigue A,Wang GP,et al.Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.J Clin Investig,2008 ; 118 (9):3132-3142.
  • 7McCormack MP,Rabbitts TH.Activation of the T-Cell Oncogene LMO2 after gene therapy for X-Linked Severe Combined Immunodeficiency.N Eng J Med,2004;350(9):913-922.
  • 8Aiuti A,Roncarolo MG.Ten years of gene therapy for primary immune deficiencies.Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program,2009:682-689.
  • 9Hacein-Bey-Abina S,Von Kalle C,Schmidt M,et al.LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.Science,2003 ;302(5644):415-419.
  • 10Howe S.Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy.J Clin Investig,2008;118(9):3143-3150.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部